| Amrutanjan Health Care Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 590006 |
NSE Symbol : AMRUTANJAN |
P/E(TTM) : 45.63 |
|
ISIN Demat : INE098F01031 |
Div & Yield% : 0.61 |
EPS(TTM) : 16.44 |
|
Book Value(₹) : 103.00 |
Market Cap(₹Cr) : 2,168.59 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 109.92 | 83.74 | 127.06 | 116.99 | 99.31 | 77.86 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 109.92 | 83.74 | 127.06 | 116.99 | 99.31 | 77.86 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.05 | 4.45 | 4.95 | 3.76 | 3.95 | 3.69 |
| Total Income | 113.96 | 88.19 | 132.01 | 120.76 | 103.26 | 81.55 |
| Total Expenditure | 96.31 | 80.19 | 110.83 | 95.42 | 92.47 | 70.70 |
| PBIDT | 17.65 | 8.00 | 21.19 | 25.34 | 10.79 | 10.85 |
| Interest | 0.06 | 0.06 | 0.05 | 0.05 | 0.03 | 0.02 |
| PBDT | 17.59 | 7.94 | 21.14 | 25.28 | 10.76 | 10.82 |
| Depreciation | 1.65 | 1.59 | 1.53 | 1.58 | 1.55 | 1.39 |
| Tax | 4.14 | 1.73 | 5.95 | 6.26 | 2.36 | 2.41 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 11.80 | 4.62 | 13.66 | 17.45 | 6.85 | 7.01 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 11.80 | 4.62 | 13.66 | 17.45 | 6.85 | 7.01 |
| EPS (Unit Curr.) | 4.08 | 1.60 | 4.72 | 6.05 | 2.36 | 2.40 |
| EPS (Adj) (Unit Curr.) | 4.08 | 1.60 | 4.72 | 6.05 | 2.36 | 2.40 |
| Calculated EPS (Unit Curr.) | 4.08 | 1.60 | 4.72 | 6.04 | 2.37 | 2.40 |
| Calculated EPS (Adj) (Unit Curr.) | 4.08 | 1.60 | 4.72 | 6.04 | 2.37 | 2.40 |
| Calculated EPS (Ann.) (Unit Curr.) | 16.32 | 6.39 | 18.90 | 24.14 | 9.48 | 9.60 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 16.32 | 6.39 | 18.90 | 24.14 | 9.48 | 9.60 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 100.00 | 0.00 | 100.00 | 0.00 | 0.00 |
| Equity | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 | 2.92 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 16.06 | 9.55 | 16.68 | 21.66 | 10.86 | 13.94 |
| PBDTM(%) | 16.00 | 9.48 | 16.64 | 21.61 | 10.83 | 13.90 |
| PATM(%) | 10.74 | 5.52 | 10.75 | 14.92 | 6.90 | 9.00 |